Abstract: For five thousand years, humanity has sought the fountain of youth. Today, the stem cells we expand in our laboratories also dream of it. Before we were born, each of us held it in our veins for a fleeting moment. HALOS Biosciences is engineering it in a bioreactor.

Company blurb: HALOS Biosciences is engineering the world's first lab-grown human fetal plasma: a synthetic, scalable, and ethical recreation of the most regenerative biochemical environment in human biology as a platform technology for cell culture and regenerative medicine.

Short Bio: Dr. Dominique Darvas, CEO MD PhD with a clinical background in emergency medicine and a first doctoral thesis in emergency blood transfusion protocols. Second specialization in anti-aging and longevity medicine at Université Paris Descartes with a second thesis in mitohormesis. Co-founder of Clinique Cleage Genève (anti-aging and aesthetic clinic in Geneva). Direct clinical experience with blood composition, therapeutic protocols, and regenerative medicine. Active in the longevity biotech community as both fellow and counsellor of the Longevity Biotech Fellowship, resident at Vitalist Bay 2025 and speaker at Synbiobeta 2026.

Biotech and Health Extension

A group of scientists, entrepreneurs, funders, and institutional allies who cooperate to advance biotechnology to reverse aging and extend human healthspan.

Seminars
Subscribe to our newsletter
Nominate a seminar presenter/topic
Share this application with colleagues who’d like to join

Zoom link:https://us02web.zoom.us/j/87184473255

Presented by

Foresight Institute Calendar

Foresight Institute supports the beneficial development of high-impact technology to make great futures more likely.

https://foresight.org
Newsletter: https://foresightinstitute.substack.com

Hosted By

Tech